Rankings
▼
Calendar
MIRM Q4 2018 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$26M
EPS (Diluted)
$-9.52
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$540,500
Free Cash Flow
-$540,500
Stock-Based Comp.
$51,000
Balance Sheet
Total Assets
$52M
Total Liabilities
$2M
Stockholders' Equity
$43M
Cash & Equivalents
$52M
← FY 2018
All Quarters
Q1 2019 →
